Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 4
1948 2
1952 1
1953 2
1954 4
1956 2
1957 3
1958 3
1959 2
1961 2
1962 2
1963 2
1965 2
1967 2
1968 2
1969 1
1973 2
1974 3
1976 2
1977 3
1978 4
1979 1
1980 1
1981 1
1982 3
1983 3
1984 4
1985 1
1986 9
1987 3
1988 6
1989 4
1990 2
1991 9
1992 3
1993 10
1994 14
1995 24
1996 54
1997 120
1998 159
1999 146
2000 191
2001 259
2002 301
2003 329
2004 402
2005 407
2006 476
2007 553
2008 518
2009 575
2010 591
2011 578
2012 648
2013 615
2014 643
2015 669
2016 623
2017 585
2018 611
2019 690
2020 764
2021 748
2022 709
2023 619
2024 138

Text availability

Article attribute

Article type

Publication date

Search Results

12,323 results

Results by year

Filters applied: . Clear all
Page 1
Mechanisms of Botulinum Toxin Type A Action on Pain.
Matak I, Bölcskei K, Bach-Rojecky L, Helyes Z. Matak I, et al. Toxins (Basel). 2019 Aug 5;11(8):459. doi: 10.3390/toxins11080459. Toxins (Basel). 2019. PMID: 31387301 Free PMC article. Review.
Already a well-established treatment for different autonomic and movement disorders, the use of botulinum toxin type A (BoNT/A) in pain conditions is now continuously expanding. ...
Already a well-established treatment for different autonomic and movement disorders, the use of botulinum toxin type
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
Solish N, Carruthers J, Kaufman J, Rubio RG, Gross TM, Gallagher CJ. Solish N, et al. Drugs. 2021 Dec;81(18):2091-2101. doi: 10.1007/s40265-021-01631-w. Epub 2021 Nov 17. Drugs. 2021. PMID: 34787840 Free PMC article. Review.
Botulinum toxin type A (BoNTA) products are widely used for therapeutic and aesthetic indications, but there is a need for longer-lasting treatments that maintain symptom relief between injections and reduce the frequency of re-treatment. ...
Botulinum toxin type A (BoNTA) products are widely used for therapeutic and aesthetic indications, but there is
Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
Yoshida K. Yoshida K. Toxins (Basel). 2021 Aug 29;13(9):605. doi: 10.3390/toxins13090605. Toxins (Basel). 2021. PMID: 34564609 Free PMC article.
The differences in analgesic effects of botulinum toxin type A were compared in 28 patients with trigeminal neuralgia, 53 patients with myofascial temporomandibular disorders, and 89 patients with the jaw closing oromandibular dystonia. The patients we …
The differences in analgesic effects of botulinum toxin type A were compared in 28 patients with trigeminal neur …
Botulinum Toxin and Smile Design.
Polo M. Polo M. Dent Clin North Am. 2022 Jul;66(3):419-429. doi: 10.1016/j.cden.2022.03.003. Epub 2022 May 31. Dent Clin North Am. 2022. PMID: 35738736 Review.
Excessive muscular contraction of lip elevator muscles is the etiology in most cases, and other factors, such as excessive vertical dimension of the maxilla and altered passive dental eruption resulting in the presence of excessive gingival tissue, account for the etiologic facto …
Excessive muscular contraction of lip elevator muscles is the etiology in most cases, and other factors, such as excessive vertical dimensio …
Botulinum Toxin in the Management of Children with Cerebral Palsy.
Multani I, Manji J, Hastings-Ison T, Khot A, Graham K. Multani I, et al. Paediatr Drugs. 2019 Aug;21(4):261-281. doi: 10.1007/s40272-019-00344-8. Paediatr Drugs. 2019. PMID: 31257556 Free PMC article. Review.
During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used medical intervention in children with cerebral palsy. ...
During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used medical intervention i …
THE EFFECT OF BOTULINUM TOXIN TYPE A IN PATIENTS WITH ESSENTIAL BLEPHAROSPASM.
Gaćina K, Lešin M, Sarajčev D, Rotim N. Gaćina K, et al. Acta Clin Croat. 2022 Nov;61(3):379-385. doi: 10.20471/acc.2022.61.03.02. Acta Clin Croat. 2022. PMID: 37492354 Free PMC article.
The aim of this study was to determine the effect of botulinum toxin type A and satisfaction in patients with essential blepharospasm. ...From the results of this study, we can determine that the use of botulinum toxin type A
The aim of this study was to determine the effect of botulinum toxin type A and satisfaction in patients with es …
Botulinum Toxin Type A Immunogenicity across Multiple Indications: An Overview Systematic Review.
Rahman E, Banerjee PS, Asghar A, Gupta NK, Mosahebi A. Rahman E, et al. Plast Reconstr Surg. 2022 Apr 1;149(4):837-848. doi: 10.1097/PRS.0000000000008904. Plast Reconstr Surg. 2022. PMID: 35139064 Review.
BACKGROUND: Botulinum toxin type A has been used to treat a wide array of neurologic, medical, and aesthetic indications. ...CONCLUSIONS: Properly designed comparative trials are required to explore the difference in the prevalence of neutralizing anti …
BACKGROUND: Botulinum toxin type A has been used to treat a wide array of neurologic, medical, and aesthetic ind …
Botulinum Toxin Type A: Review and Its Role in the Dental Office.
Miller J, Clarkson E. Miller J, et al. Dent Clin North Am. 2016 Apr;60(2):509-21. doi: 10.1016/j.cden.2015.11.007. Dent Clin North Am. 2016. PMID: 27040299 Review.
For the general dentist, the use of botulinum toxin type A (BTA) confers the ability to exert control over the soft tissues surrounding the mouth to better create a harmonious smile. ...
For the general dentist, the use of botulinum toxin type A (BTA) confers the ability to exert control over the s …
Applicability of botulinum toxin type A in paediatric neurogenic bladder management.
Scheepe JR, Blok BF, 't Hoen LA. Scheepe JR, et al. Curr Opin Urol. 2017 Jan;27(1):14-19. doi: 10.1097/MOU.0000000000000352. Curr Opin Urol. 2017. PMID: 27748667 Review.
PURPOSE OF REVIEW: The purpose of this article is to provide an overview about the applicability of botulinum toxin type A (BTX-A) in paediatric neurogenic bladder based on the recently published literature combined with hypothetical notes and future p …
PURPOSE OF REVIEW: The purpose of this article is to provide an overview about the applicability of botulinum toxin type
12,323 results
You have reached the last available page of results. Please see the User Guide for more information.